Aerozest 0.31mg Respules 2.5ml

Introduction About AEROZEST 0.31MG RESPULES

AEROZEST 0.31MG RESPULES contains Levosalbutamol which belongs to the group of medicines called Bronchodilators. It is indicated in the management or management of bronchospasm (constriction of airways) in adults, adolescents, and children between 6-11 years old with reversible obstructive airway disease.

Your doctor might ask you to take several diagnostic tests before starting the management with AEROZEST 0.31MG RESPULES.

It should be used with caution in patients having cardiovascular disorders (coronary insufficiency, cardiac arrhythmias, and high blood pressure), kidney diseases, epilepsy, overactive thyroid gland, and diabetes.

Caution must be exercised while using AEROZEST 0.31MG RESPULES in pregnant and breast-feeding women. Consult with your doctor before using.

AEROZEST 0.31MG RESPULES is not recommended for use in children below 6 years of age. Consult your doctor immediately if you experience any side effects.

Uses Of AEROZEST 0.31MG RESPULES

• Used to manage bronchospasm (constriction of airways) in reversible obstructive airway disease

How AEROZEST 0.31MG RESPULES Works

AEROZEST 0.31MG RESPULES helps in the management of bronchospasm acts by relaxing smooth muscle in the bronchial tubes (airway) to increase air flow and relieve shortness of breath by activation of an enzyme which inhibits the release of cells called mast cells which are responsible for causing asthma.

How to use AEROZEST 0.31MG RESPULES

Use AEROZEST 0.31MG RESPULES as advised by your physician. It is for oral inhalational use only. It is administered by nebulisation using with nebuliser (with a face mask or mouthpiece) which is connected to an air compressor. Your doctor will guide on how to use the nebuliser. Do not exceed the recommended dose of AEROZEST 0.31MG RESPULES. Check the label for directions before use.

Your doctor will decide the correct dose and duration of AEROZEST 0.31MG RESPULES for you depending upon your age, body weight and disease condition.

Side Effects Of AEROZEST 0.31MG RESPULES

Warning & Precautions

Pregnancy

AEROZEST 0.31MG RESPULES should be used with caution in pregnant women or women planning to have a baby as safety and effectiveness to the baby and mother has not been established yet. Dose will be adjusted by your doctor. Consult your doctor before using it.

Breastfeeding

AEROZEST 0.31MG RESPULES should be used with caution in breastfeeding women as it is not known if AEROZEST 0.31MG RESPULES passes through mother’s milk. Consult your doctor before using it.

Kidney

AEROZEST 0.31MG RESPULES should be used with caution in patients with kidney problems. Consult your doctor before using it.

Allergy

Do not use AEROZEST 0.31MG RESPULES if you are allergic to Levosalbutamol or any other ingredients of this medicine.

Heart Disease

AEROZEST 0.31MG RESPULES should be used with caution in patients with heart diseases such as coronary insufficiency, irregular heartbeat, and high blood pressure. Consult your doctor before using.

Interactions

A. Drug–Drug Interactions:

Before using AEROZEST 0.31MG RESPULES inform your doctor if you are taking any of the following medicine:

• other short acting bronchodilators such as albuterol, terbutaline (used to manage asthma)
• beta blockers such as metoprolol, propranolol (used to manage irregular heartbeat)
• digoxin (used to manage heart diseases)
• diuretics (water medicines) such as furosemide, chlorothiazide
• isocarboxazid, tricyclic antidepressants such as nortriptyline, amitriptyline (used to manage depression)
• halothane, enflurane, isoflurane, desflurane, sevoflurane (used as anaesthetics)
• corticosteroids (anti-inflammatory drug Ex. dexamethasone, hydrocortisone)

Overdosage:

If you or anyone else accidentally use too much of AEROZEST 0.31MG RESPULES, consult your doctor immediately or visit the nearby hospital. The symptoms of overdosage of AEROZEST 0.31MG RESPULES are fastened heart rate, nervousness, headache, tremor, dry mouth, palpitation, nausea, dizziness, fatigue, and sleeplessness.

Synopsis

More Information

• Keep AEROZEST 0.31MG RESPULES out of reach of children
• Store below at room temperature 30°C

FAQs About AEROZEST 0.31MG RESPULES

What is AEROZEST 0.31MG RESPULES and why is it prescribed?

AEROZEST 0.31MG RESPULES contains Levosalbutamol which belongs to the group of medicines called Bronchodilators. It is indicated in the management or management of bronchospasm (constriction of airways) in adults, adolescents, and children between 6-11 years old with reversible obstructive airway disease.

Can AEROZEST 0.31MG RESPULES be given to patients having heart disease?

AEROZEST 0.31MG RESPULES may cause fastened heart rate. It should be used with caution in patients with heart diseases such as coronary insufficiency, irregular heartbeat, and high blood pressure. Consult your doctor before using.

Is it safe to use AEROZEST 0.31MG RESPULES in diabetic patients?

AEROZEST 0.31MG RESPULES may cause an increase in blood sugar level. Therefore, caution must be exercised while using AEROZEST 0.31MG RESPULES in diabetic patients and should be kept under close observation. Consult your doctor before using.

How to use AEROZEST 0.31MG RESPULES?

Use AEROZEST 0.31MG RESPULES as advised by your physician. It is for oral inhalational use only. It is administered by nebulisation using with nebuliser (with a face mask or mouthpiece) which is connected to an air compressor. Your doctor will decide the correct dose and duration of AEROZEST 0.31MG RESPULES for you depending upon your age, body weight and disease condition.

Can I stop using AEROZEST 0.31MG RESPULES if I feel better?

You should not stop using AEROZEST 0.31MG RESPULES until your doctor asks you to. Keep using AEROZEST 0.31MG RESPULES for the whole time it has been prescribed to you. If you wish to discontinue, ask for your doctor’s advice.

References

1. K.D. Tripathi. Respiratory System Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 222.

2. Mukesh Kumar Gupta, Meenu Singh. Evidence based review on Levosalbutamol. NIH National Library of Medicine, National centre for biotechnology information. Pubmed.gov. February 2007. [Accessed on 18th July 2022] https://pubmed.ncbi.nlm.nih.gov/17337829/

3. J L Schlienger, M J Compagnie, P Dellenbach, F Stephan. Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl). NIH National Library of Medicine, National centre for biotechnology information. Pubmed.gov. September 1980. [Accessed on 18th July 2022] https://pubmed.ncbi.nlm.nih.gov/6106923/

4. NIH National Library of Medicine, National centre for biotechnology information. Pubchem. Levalbuterol. [Accessed on 18th July 2022] https://pubchem.ncbi.nlm.nih.gov/compound/Levalbuterol

5. Cipla Ltd. Levolin Respules. Ciplamed. [Revised in February 2021] [Accessed on 18th July 2022] https://www.ciplamed.com/content/levolin-respules

6. Drugbank. Levosalbutamol. [Revised in October 2021] [Accessed on 19th July 2022] https://go.drugbank.com/drugs/DB13139

Useful Diagnostic Tests

• Chest X ray
• Pulmonary Function Test
• Kidney function test

Author Details

Written By Dr. Janet.C - Pharm.D

Reviewed For Accuracy By Dr. Rajnikant - MBBS, MD (Physiology)

Last updated on 26 Nov 2022 | 10:56 PM(IST)